Literature DB >> 15772138

Modelling time-kill studies to discern the pharmacodynamics of meropenem.

Vincent H Tam1, Amy N Schilling, Michael Nikolaou.   

Abstract

OBJECTIVES: Time-kill studies are commonly used in investigations of new antimicrobial agents. However, they typically provide descriptive information on pharmacodynamics. We developed a mathematical model to capture the relationship between microbial burden and antimicrobial agent concentrations.
METHODS: Time-kill studies were performed with 10(8) cfu/mL of Pseudomonas aeruginosa at baseline. Meropenem at 0, 0.25, 1, 4, 16 and 64 x MIC was used (MIC = 1 mg/L). Serial samples were obtained to quantify bacterial burden over 24 h. The data were analysed by a population analysis using the non-parametric adaptive grid program. The rate of change of bacteria over time was expressed as the difference between linear bacterial growth rate and sigmoidal kill rate. Regrowth was attributed to adaptation, which was explicitly modelled as increase in C(50k) (concentration to achieve 50% maximal kill rate), using a saturable function of selective pressure (both meropenem concentration and time).
RESULTS: The best-fit model consisted of eight parameters and the fit to the data was satisfactory. The r2 of maximum a-posteriori probability Bayesian predictions based on the mean parameter estimates was 0.984. Maximal killing rate at baseline was found to be 4.7 h(-1); C(90k) was achieved with meropenem at 5.0 mg/L. The model was validated by time-kill studies using 2x and 32x MIC of meropenem.
CONCLUSIONS: Our model reasonably described and predicted the time course of P. aeruginosa in time-kill studies, and provided quantitative information on the pharmacodynamics of meropenem. The structural model appeared robust and could be used to provide a realistic expectation of the killing performance of antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772138     DOI: 10.1093/jac/dki086

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  44 in total

1.  Mathematical modeling to characterize the inoculum effect.

Authors:  Pratik Bhagunde; Kai-Tai Chang; Renu Singh; Vandana Singh; Kevin W Garey; Michael Nikolaou; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

2.  Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.

Authors:  Elisabet I Nielsen; Anders Viberg; Elisabeth Löwdin; Otto Cars; Mats O Karlsson; Marie Sandström
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

3.  A general model-based design of experiments approach to achieve practical identifiability of pharmacokinetic and pharmacodynamic models.

Authors:  Federico Galvanin; Carlo C Ballan; Massimiliano Barolo; Fabrizio Bezzo
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-06-04       Impact factor: 2.745

4.  Mathematical model to quantify the effects of risk factors on carbapenem-resistant Acinetobacter baumannii.

Authors:  Michelle W Tan; David C Lye; Tat-Ming Ng; Michael Nikolaou; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

5.  Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Vincent H Tam; Samer Kabbara; Giao Vo; Amy N Schilling; Elizabeth A Coyle
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa.

Authors:  Vincent H Tam; Amy N Schilling; Shadi Neshat; Keith Poole; David A Melnick; Elizabeth A Coyle
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

7.  Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model.

Authors:  Elisabet I Nielsen; Otto Cars; Lena E Friberg
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

8.  Concentration-effect relationship of ceftazidime explains why the time above the MIC is 40 percent for a static effect in vivo.

Authors:  Johan W Mouton; Nieko Punt; Alexander A Vinks
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

9.  In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures.

Authors:  Aryun Kim; Mary Anne Banevicius; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

10.  Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.

Authors:  Stephan Schmidt; Sreedharan Nair Sabarinath; April Barbour; Darren Abbanat; Prasarn Manitpisitkul; Sue Sha; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.